Natural History of Crohn's Disease in Elderly Patients Diagnosed Over the Age of 70 Years: A Population-Based Study.
Fiche publication
Date publication
juillet 2016
Journal
Inflammatory bowel diseases
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Fumery M, Pariente B, Sarter H, Charpentier C, Armengol Debeir L, Dupas JL, Coevoet H, Peyrin-Biroulet L, dʼAgay L, Gower-Rousseau C, Savoye G,
Lien Pubmed
Résumé
Elderly onset (>60 yrs at diagnosis) Crohn's disease (CD) seems to be associated with a better outcome than when diagnosed earlier in life. The aim of this study was to compare the natural history of patients with CD older than 70 years at diagnosis with that of elderly patients diagnosed between 60 and 70 years in the EPIMAD population-based registry.
Mots clés
Adrenal Cortex Hormones, therapeutic use, Age of Onset, Aged, Anti-Inflammatory Agents, Non-Steroidal, therapeutic use, Colectomy, Colon, pathology, Crohn Disease, diagnosis, Disease Progression, Female, Follow-Up Studies, Humans, Ileum, surgery, Immunosuppressive Agents, therapeutic use, Incidence, Male, Mesalamine, therapeutic use, Middle Aged, Phenotype, Sex Distribution, Tumor Necrosis Factor-alpha, antagonists & inhibitors
Référence
Inflamm. Bowel Dis.. 2016 07;22(7):1698-707